SP CARBIMAZOLE 5; SPPL CARBIMAZOLE 5; SEED PHARMA CARBIMAZOLE 20; SPPL CARBIMAZOLE 20; SP CARBIMAZOLE 20; WP CARBIMAZOLE 5; WP CARBIMAZOLE 20; SEED PHARMA CARBIMAZOLE 5 (Seed Pharma Pty Ltd)
Product name
SP CARBIMAZOLE 5; SPPL CARBIMAZOLE 5; SEED PHARMA CARBIMAZOLE 20; SPPL CARBIMAZOLE 20; SP CARBIMAZOLE 20; WP CARBIMAZOLE 5; WP CARBIMAZOLE 20; SEED PHARMA CARBIMAZOLE 5
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
137 (255 working days)
Active ingredients
carbimazole
Registration type
New generic medicine
Indication
SP CARBIMAZOLE 5; SPPL CARBIMAZOLE 5; SEED PHARMA CARBIMAZOLE 20; SPPL CARBIMAZOLE 20; SP CARBIMAZOLE 20; WP CARBIMAZOLE 5; WP CARBIMAZOLE 20; SEED PHARMA CARBIMAZOLE 5 (tablet) is indicated for therapy of hyperthyroidism. Definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. Preparation for thyroidectomy. Before and after radioactive iodine treatment.